Literature DB >> 25919115

Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors.

I-Lun Shih1, Ruoh-Fang Yen2, Chi-An Chen3, Bang-Bin Chen1, Shwu-Yuan Wei1, Wen-Chun Chang3, Bor-Ching Sheu3, Wen-Fang Cheng3, Yao-Hui Tseng1, Xin-Jia Chen1, Chi-Hau Chen3, Lin-Hung Wei4, Ying-Cheng Chiang3, Pao-Ling Torng3, Men-Luh Yen3, Tiffany Ting-Fang Shih1.   

Abstract

PURPOSE: To evaluate the correlation between maximum standardized uptake value (SUVmax ) and minimum apparent diffusion coefficient (ADCmin ) of endometrial cancer derived from an integrated positron emission tomography / magnetic resonance (PET/MR) system and to determine their correlation with pathological prognostic factors.
MATERIALS AND METHODS: This prospective study was approved by the Institutional Review Board of the hospital, and informed consent was obtained. Between April and December 2014, 47 consecutive patients with endometrial cancer were enrolled and underwent simultaneous PET/MR examinations before surgery. Thirty-six patients with measurable tumors on PET/MR were included for image analysis. Pearson's correlation coefficient was used to evaluate the correlation between SUVmax and ADCmin of the tumors. The Mann-Whitney U-test was utilized to evaluate relationships between these two imaging biomarkers and pathological prognostic factors.
RESULTS: The mean SUVmax and ADCmin were 14.7 ± 7.1 and 0.48 ± 0.13 × 10(-3) mm(2) /s, respectively. A significant inverse correlation was found between SUVmax and ADCmin (r = -0.53; P = 0.001). SUVmax was significantly higher in tumors with advanced stage, deep myometrial invasion, cervical invasion, lymphovascular space involvement, and lymph node metastasis (P < 0.05). ADCmin was lower in tumors with higher grade, advanced stage, and cervical invasion (P < 0.05). The ratio of SUVmax to ADCmin was higher in tumors with higher grade, advanced stage, deep myometrial invasion, cervical invasion, lymphovascular space involvement, and lymph node metastasis (P < 0.05).
CONCLUSION: SUVmax and ADCmin of endometrial cancer derived from integrated PET/MR are inversely correlated and are associated with pathological prognostic factors.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  endometrial cancer; magnetic resonance imaging; positron emission tomography

Mesh:

Substances:

Year:  2015        PMID: 25919115     DOI: 10.1002/jmri.24932

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

1.  Endometrial cancer with cervical stromal invasion: diagnostic accuracy of diffusion-weighted and dynamic contrast enhanced MR imaging at 3T.

Authors:  Gigin Lin; Yu-Ting Huang; Angel Chao; Yu-Chun Lin; Lan-Yan Yang; Ren-Chin Wu; Hsin-Ying Lu; Shu-Hang Ng; Koon-Kwan Ng; Chyong-Huey Lai
Journal:  Eur Radiol       Date:  2016-09-09       Impact factor: 5.315

Review 2.  PET/MRI: Where might it replace PET/CT?

Authors:  Eric C Ehman; Geoffrey B Johnson; Javier E Villanueva-Meyer; Soonmee Cha; Andrew Palmera Leynes; Peder Eric Zufall Larson; Thomas A Hope
Journal:  J Magn Reson Imaging       Date:  2017-03-30       Impact factor: 4.813

Review 3.  FDG Whole-Body PET/MRI in Oncology: a Systematic Review.

Authors:  Hyun Woo Kwon; Ann-Katharina Becker; Jin Mo Goo; Gi Jeong Cheon
Journal:  Nucl Med Mol Imaging       Date:  2016-04-07

4.  PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.

Authors:  Bang-Bin Chen; Yu-Wen Tien; Ming-Chu Chang; Mei-Fang Cheng; Yu-Ting Chang; Chih-Horng Wu; Xin-Jia Chen; Ting-Chun Kuo; Shih-Hung Yang; I-Lun Shih; Hong-Shiee Lai; Tiffany Ting-Fang Shih
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-03-19       Impact factor: 9.236

Review 5.  What's New in Imaging for Gynecologic Cancer?

Authors:  Sairah R Khan; Mubarik Arshad; Kathryn Wallitt; Victoria Stewart; Nishat Bharwani; Tara D Barwick
Journal:  Curr Oncol Rep       Date:  2017-11-06       Impact factor: 5.075

6.  Correlation of Minimum Apparent Diffusion Coefficient and Maximum Standardized Uptake Value of the Primary Tumor with Clinicopathologic Characteristics in Endometrial Cancer.

Authors:  Evrim Sürer Budak; Tayfun Toptaş; Funda Aydın; Ali Ozan Öner; Can Çevikol; Tayup Şimşek
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-05

7.  Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.

Authors:  Stefanie J Hectors; Mathilde Wagner; Cecilia Besa; Wei Huang; Bachir Taouli
Journal:  Contrast Media Mol Imaging       Date:  2018-10-03       Impact factor: 3.161

8.  Metabolic Volumetric Parameters in 11C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer.

Authors:  Jing-Ren Tseng; Lan-Yan Yang; Yu-Chun Lin; Chung-Yi Liu; See-Tong Pang; Ji-Hong Hong; Tzu-Chen Yen; Li-Jen Wang
Journal:  Contrast Media Mol Imaging       Date:  2018-11-05       Impact factor: 3.161

Review 9.  Quantitative imaging of uterine cancers with diffusion-weighted MRI and 18-fluorodeoxyglucose PET/CT.

Authors:  Madeleine Sertic; Aoife Kilcoyne; Onofrio Antonio Catalano; Susanna I Lee
Journal:  Abdom Radiol (NY)       Date:  2021-07-23

10.  Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany.

Authors:  D L Bailey; B J Pichler; B Gückel; G Antoch; H Barthel; Z M Bhujwalla; S Biskup; S Biswal; M Bitzer; R Boellaard; R F Braren; C Brendle; K Brindle; A Chiti; C la Fougère; R Gillies; V Goh; M Goyen; M Hacker; L Heukamp; G M Knudsen; A M Krackhardt; I Law; J C Morris; K Nikolaou; J Nuyts; A A Ordonez; K Pantel; H H Quick; K Riklund; O Sabri; B Sattler; E G C Troost; M Zaiss; L Zender; Thomas Beyer
Journal:  Mol Imaging Biol       Date:  2018-02       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.